• No image available for this medication
    • PEGASYS

    • QTY 4
    • 180MCG/ML
    • VIAL

PEGINTERFERON ALFA-2a (peg in ter FEER on AL fa 2 a) is a man-made drug that acts like a protein made by the body. It is used to treat chronic hepatitis B and C infections.


PEGASYS Lifestyle Interactions

  • Peginterferon Alfa-2a 180mcg/1mL, Solution for injection

    Interaction: Alcohol
    Severity: Major
    Notes for Consumers: You should alcoholic drinks while receiving Peginterferon alfa-2a therapy. Alcohol may increase the risk for liver damage while on this treatment. You may feel drowsy, or more tired when taking these drugs together. Do not drive or operate machinery until you know how Peginterferon alfa-2a affects you.
    Notes for Professionals: Patients should be advised to avoid drinking alcohol to reduce the chance of injury to the liver during peginterferon alfa-2a treatment. Alcohol may also potentiate drowsiness and dizziness. Patients who develop dizziness, confusion, somnolence, and fatigue with peginterferon alfa-2a treatment should be cautioned to avoid driving or operating machinery.

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.